Vetter News

Filter
News
Interview with Peter Soelkner: What’s next for the injectable drug market?

11/10/2021 | Peter Soelkner shares his insights on the impact of new trends and molecules, and how Vetter is adapting to stay ahead.

Watch now

cleanroom employee
CDMO Insights
Well prepared for the revision of the EU GMP Annex 1

10/20/2021 | The Annex 1 of the EU GMP Guide "Manufacture of Sterile Medicinal Products" is considered the most important European regulatory standard for the…

Read more

PDA Drug Delivery Innovation Award 2021
News
Vetter/Syntegon partnership scores PDA Drug Delivery Innovation Award

10/05/2021 | Together our teams are breaking new ground in small batch filling. Learn more about this award-winning collaboration.

Read more

consultant discussing with pharma client
CDMO Insights
A Strong Partnership in Drug Development – How CDMOs and Consultants Mutually Benefit Their Clients

10/01/2021 | The field of drug development can be risky and a costly investment - mistakes can mean the success or failure of a compound or even a company.

Read more

Building with CO2neutral Slogan
News
Corporate Sites Around the World are CO2-Neutral

09/21/2021 | Vetter's Contribution to Climate Protection

Read more

flexible production cell
News
Collaborative innovation in small batch manufacturing

09/14/2021 | Small filling runs create unique challenges. See how Vetter and Syntegon are combining their expertise to solve them

Read more

woman with pen
CDMO Insights
Injectable Drug Delivery Trends

08/11/2021 | How Global Trends Are Driving Patient-Centricity in Parenteral Products.

Read more

Vetter development service office in Rankweil, Austria
News
New clinical manufacturing site now integrated

07/21/2021 | After only one year our location in Austria has been modified to the high Vetter quality standards as it prepares to begin manufacturing.

Read more

Colleagues and customer in meeting with syringe
CDMO Insights
Clinical manufacturing on time and within budget

06/29/2021 | The key to successful development and guiding a drug to approval is early planning.

Read more

Women in analytical science laboratory has discovered a solution which enables a efficient and sequence-specific ID determination.
CDMO Insights
ID determination of oligonucleotides

06/21/2021 | Fast, safe and efficient: the new Vetter ID determination of oligonucleotides.

Read more

Working at her desk
Careers
Vetter is a “Great place to work”

06/14/2021 | 92 percent of our colleagues in Chicago named Vetter a “Great Place to Work” company!

Read more

News
Innovation and Responsibility for Patients

06/09/2021 | In this article Senior Vice President Kai Vogt talks about the opportunities of digital transformation at Vetter.

Read more